NorthWest Biotherapeutics Inc (NWBO)

[eagle8]

autologous assassin 🇺🇸🇨🇦🇺🇦🇮🇱
@flaskworks
4️⃣ Final Conclusion: Strong Signals Toward HIV or Other Infectious Disease Research With $NWBO IP

🚀 Advent Bio’s new CL2 lab strongly suggests R&D expansion into infectious diseases, potentially including HIV dendritic cell vaccine development.

🔬 The Rockefeller HIV dendritic cell trial (NCT01127464) proves that DC-based HIV vaccines work and that PolyICLC enhances them, making this an area worth exploring.

💰 With Advent scaling up biotech partnerships, they could be positioning themselves to take on broader immunotherapy challenges beyond cancer.

🔥 Bottom Line: NWBO’s CDMO (Advent Bio) may now be entering the HIV vaccine race, using its expertise in dendritic cell immunotherapy.

4️⃣ Final Conclusion: Strong Signals Toward HIV or Other Infectious Disease Research With $NWBO IP

🚀 Advent Bio’s new CL2 lab strongly suggests R&D expansion into infectious diseases, potentially including HIV dendritic cell vaccine development.

🔬 The Rockefeller HIV dendritic… pic.twitter.com/eXuBG1Aa8C

— autologous assassin 🇺🇸🇨🇦🇺🇦🇮🇱 (@flaskworks) March 15, 2025